CDK12 and breast cancer: In particular, both canonical and non-canonical splicing factors kinases, such as SRSF protein kinase 1 (SRPK1) or cyclin dependent kinase 12 (CDK12), were shown to be aberrantly expressed in BC cells and to promote tumorigenesis through AS regulation [17, 18].